Injectable vaccine compositions
Specialised sub-micron vaccine particles with an antigen shell and adjuvant core boost immune response while lowering patient dosage.
These specialised sub-micron vaccine particles consist of a variable antigen shell surrounding an adjuvant core, designed to enhance immunogenicity while reducing the required vaccine dosage per patient. They hold potential for use in both traditional vaccines and tumour lysate-based cancer vaccines.
Applications: Vaccines, Prophylactic treatment
| Features | Benefits |
|---|---|
| Ability to quickly incorporate any protein-derived antigen into the nanoparticle shell | Rapid adjustment of vaccine particle to pathogen of interest |
| A wide array of adjuvants or adjuvant combinations can be loaded into the nanoparticle core | Enhanced immune response, reducing the dose of vaccine per patient required |
| Antigen and adjuvant remain co-located post injection | Promotion of optimal immunogenicity |
| Particles have a similar size and morphology to a virus | Further enhancement of immune response |
| Established synthesis is a high yielding, two-step process that is compatible with scaling to a cGMP level | Rapid go-to-market and reduced manufacturing costs |
Patented and Available For
- Co-development
- Consulting
- Licensing